Ubs Group Ag Silo Pharma, Inc. Transaction History

Ubs Group Ag

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.38 - $1.95 $44,807 - $63,314	-32,469 Reduced 98.86%	374 $0
Q4 2023 Feb 09, 2024	BUY	$1.3 - $1.84 $42,695 - $60,431	32,843 New	32,843 $47,000
Q4 2022 Feb 08, 2023	SELL	$2.61 - $5.94 $4,149 - $9,444	-1,590 Reduced 23.39%	5,209 $17,000
Q3 2022 Nov 10, 2022	BUY	$4.88 - $10.0 $33,179 - $67,990	6,799 New	6,799 $37,000

338K

Ticker SILO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,137,910
Market Cap $2.7M
Description
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.